NCT00134693 - A Single Dose Of Compound SB-681323 Compared To Prednisolone On A Protein That Is an Indicator For Rheumatoid Arthritis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 21, 2005

Primary Completion Date

August 3, 2006

Study Completion Date

August 3, 2006

Conditions

Arthritis, Rheumatoid

Interventions

DRUG

Prednisolone

DRUG

SB-681323

Trial Locations (28)

2010

GSK Investigational Site, Darlinghurst

4102

GSK Investigational Site, Woolloongabba

4814

GSK Investigational Site, Douglas

5011

GSK Investigational Site, Woodville

5041

GSK Investigational Site, Daw Park

6008

GSK Investigational Site, Shenton Park

7000

GSK Investigational Site, Hobart

12163

GSK Investigational Site, Berlin

13125

GSK Investigational Site, Berlin

14059

GSK Investigational Site, Berlin

14109

GSK Investigational Site, Berlin

31134

GSK Investigational Site, Hildesheim

34295

GSK Investigational Site, Montpellier

78054

GSK Investigational Site, Villingen-Schwenningen

80054

GSK Investigational Site, Amiens

115522

GSK Investigational Site, Moscow

150003

GSK Investigational Site, Yaroslavl

390026

GSK Investigational Site, Ryazan

620102

GSK Investigational Site, Yekaterinburg

09111

GSK Investigational Site, Chemnitz

04107

GSK Investigational Site, Leipzig

04229

GSK Investigational Site, Leipzig

CB2 0QQ

GSK Investigational Site, Cambridge

WN6 9EP

GSK Investigational Site, Wigan

L9 7AL

GSK Investigational Site, Liverpool

NE1 4LP

GSK Investigational Site, Newcastle

OX3 7LP

GSK Investigational Site, Oxford

S10 2RX

GSK Investigational Site, Sheffield